What is the role of Erceflora (Lactobacillus acidophilus and Bifidobacterium bifidum) in probiotic supplementation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Role of Erceflora (Lactobacillus acidophilus and Bifidobacterium bifidum) in Probiotic Supplementation

Erceflora, containing Lactobacillus acidophilus and Bifidobacterium bifidum, is effective for treating acute diarrhea and may provide benefits for gut health, but has insufficient evidence for routine use in other conditions. 1

Evidence for L. acidophilus and B. bifidum Combination

  • The combination of Lactobacillus acidophilus and Bifidobacterium bifidum has demonstrated effectiveness in treating acute diarrhea, significantly shortening the duration (34-35 hours vs 58 hours with placebo) and reducing stool frequency 1
  • This probiotic combination maintains its efficacy even when stored at room temperature (28-32°C), making it practical for use in tropical or subtropical countries 1
  • L. acidophilus and B. bifidum supplementation has shown potential to decrease serum total cholesterol and LDL-cholesterol levels in hypercholesterolemic patients over a six-week period 2

Mechanism of Action

  • Probiotics like Erceflora exert beneficial effects through multiple mechanisms:
    • Lowering intestinal pH
    • Decreasing colonization and invasion by pathogenic organisms
    • Modifying host immune response 3
  • Bifidobacterium species are particularly important for gut health as they can act as "ecosystem engineers," transforming the composition and function of the gut microbiome 4
  • Lactobacillus species may provide benefits through antimicrobial and competitive exclusion activities, limiting the growth of pathogenic bacteria 4

Evidence-Based Applications

Strong Evidence

  • Acute Diarrhea: The combination of L. acidophilus and B. bifidum is effective in reducing duration and frequency of diarrhea 1
  • Antibiotic-Associated Diarrhea: The 3-strain combination of L. acidophilus, L. delbrueckii subsp bulgaricus, and B. bifidum reduces the risk of C. difficile infection when given with antibiotics (RR, 0.35; 95% CI, 0.15–0.85) 4

Limited Evidence

  • Hypercholesterolemia: May decrease serum total cholesterol and LDL-cholesterol levels, but insufficient evidence for routine recommendation 2
  • General Gut Health: May help maintain appropriate balance of gut bacteria and improve digestion 4
  • Immune Function: May boost immunological function, but more research is needed 4

Dosage and Administration

  • For clinical effectiveness, probiotics should typically contain several billion microorganisms to ensure adequate gut colonization 3
  • In studies showing efficacy for acute diarrhea, L. acidophilus and B. bifidum were administered three times daily 1
  • For cholesterol-lowering effects, the combination was taken three times daily for six weeks 2
  • For prevention of C. difficile infection, the 3-strain combination including these bacteria showed effectiveness when administered during antibiotic treatment 4

Safety Considerations

  • Probiotics containing L. acidophilus and B. bifidum are generally considered safe and well-tolerated 3
  • Most common side effects include bloating and flatulence 3
  • Caution is advised in:
    • Critically ill patients
    • Severely immunocompromised individuals
    • Patients with central venous catheters (due to rare risk of systemic infections) 3
  • Bacteria-derived probiotics should be separated from antibiotics by at least two hours 3

Limitations and Caveats

  • Probiotic benefits associated with one strain or species do not necessarily apply to others 3
  • The probiotic market is relatively unregulated, with claims often transferred from tested products to those with material differences in formulation 5
  • Evidence for many potential applications remains limited or conflicting 6
  • For metabolic diseases (diabetes, dyslipidemia, obesity, hypertension), more well-conducted studies are needed to demonstrate efficacy 5

Clinical Decision Making

  1. For acute diarrhea: Erceflora is a good first-line option, with strong evidence for reducing duration and frequency 1
  2. For antibiotic-associated diarrhea: Consider Erceflora as preventive therapy, especially in high-risk patients 4
  3. For hypercholesterolemia: May be considered as an adjunct to standard therapy, but not as a replacement 2
  4. For general gut health in healthy individuals: Benefits may be transient and limited to supplement-specific bacterial increases 7

Remember that while Erceflora may provide benefits for specific conditions, it should not replace appropriate medical treatment for serious conditions, and its effects may vary between individuals.

References

Research

Probiotics.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Evidence for Oral Probiotics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Recommendations for probiotic use.

Journal of clinical gastroenterology, 2006

Research

A review of probiotic supplementation in healthy adults: helpful or hype?

European journal of clinical nutrition, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.